A 8979 New York Assembly · 2025 Regular Session

Relates to the sale of medetomidine

Summary
Provides that no corporation, partnership, limited liability company, firm, online platform, or any other business entity doing business in this state shall knowingly sell, offer for sale, or deliver medetomidine to individuals without proof of its intended use for institutional, veterinary, or scientific purposes.
Bill status in committee 1 of 4 stages cleared
Introduction
Aug 2025
Committee Review
Floor Vote
Governor
Introduced Aug 13, 2025 Last action Jan 7, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO CONSUMER AFFAIRS AND PROTECTION
lower
Aug 13, 2025
Committee
REFERRED TO CONSUMER AFFAIRS AND PROTECTION
lower
1 primary · 13 co-sponsors

Sponsors